Palbociclib

Pfizer Inc. (NYSE: PFE), Amgen, Inc. (NASDAQ: AMGN) and Eli Lilly and Co (NYSE: LLY) received favorable opinions from the European Medicines Agency in response to their respective applications. Pfizer's IBRANCE® Pfizer disclosed that the European Medicines Agency (EMA)'s Committee for Medicinal...

Pfizer Inc. (NYSE: PFE) came out with better-than-expected fourth quarter earnings results on Tuesday. However, the earnings forecasts of 2015 provided by the company were way below Wall Street expectations. The company cited strengthening dollar and patent expiration as the reasons behind lower...

The Dow Jones Industrial Average is off to a rough start in 2015. More than two weeks into the year, it is down 1.75 percent, and half of its 30 components share prices have dropped during that span. However, there have been a few bright spots for the Dow. Here are the five best-performing Dow...

U.S. stocks rose today as investors and traders felt that there were plenty of bargains in the market to be found. "Today is just a bounce. I don't think there is really that much behind it, other than some bargain hunters stepping in," Robert Pavlik, a chief market strategist said to CNBC....

U.S. stocks continued its losses on an accelerated basis on Monday. Investors are in clear panic mode following a report that U.S manufacturing activity expanded at a slower pace in January. The Dow plunged more than 300 points while the S&P 500 and Nasdaq both fell more than two percent as...